Rankings
▼
Calendar
ORIC
ORIC Pharmaceuticals, Inc.
$1B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$900,000
Operating Income
-$23M
Net Income
-$22M
EPS (Diluted)
$-15.62
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$217
Balance Sheet
Total Assets
$30M
Total Liabilities
$4M
Stockholders' Equity
$26M
Cash & Equivalents
$26M
← FY 2018
All Quarters
ORIC FY 2017 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
